2002 related articles for article (PubMed ID: 9530051)
1. Hepatocellular carcinoma in North America: a multiinstitutional study of appearance on T1-weighted, T2-weighted, and serial gadolinium-enhanced gradient-echo images.
Kelekis NL; Semelka RC; Worawattanakul S; de Lange EE; Ascher SM; Ahn IO; Reinhold C; Remer EM; Brown JJ; Bis KG; Woosley JT; Mitchell DG
AJR Am J Roentgenol; 1998 Apr; 170(4):1005-13. PubMed ID: 9530051
[TBL] [Abstract][Full Text] [Related]
2. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
3. Serial MR imaging of small arterially-enhancing liver lesions in patients with chronic liver disease.
Korpraphong P; Leyendecker JR; Hildebolt CF; Narra V; Bae KT; Brown JJ
J Med Assoc Thai; 2009 Apr; 92(4):548-55. PubMed ID: 19374308
[TBL] [Abstract][Full Text] [Related]
4. Hypervascular hepatocellular carcinoma 1 cm or smaller in patients with chronic liver disease: characterization with gadoxetic acid-enhanced MRI that includes diffusion-weighted imaging.
Kim JE; Kim SH; Lee SJ; Rhim H
AJR Am J Roentgenol; 2011 Jun; 196(6):W758-65. PubMed ID: 21606265
[TBL] [Abstract][Full Text] [Related]
5. Can a multiphasic contrast-enhanced three-dimensional fast spoiled gradient-recalled echo sequence be sufficient for liver MR imaging?
Coulam CH; Chan FP; Li KC
AJR Am J Roentgenol; 2002 Feb; 178(2):335-41. PubMed ID: 11804888
[TBL] [Abstract][Full Text] [Related]
6. Treatment of hepatocellular carcinoma with percutaneous ethanol injection: evaluation with contrast-enhanced MR imaging.
Bartolozzi C; Lencioni R; Caramella D; Mazzeo S; Ciancia EM
AJR Am J Roentgenol; 1994 Apr; 162(4):827-31. PubMed ID: 8141000
[TBL] [Abstract][Full Text] [Related]
7. Characterization of focal hepatic lesions with ferumoxides-enhanced MR imaging: utility of T1-weighted spoiled gradient recalled echo images using different echo times.
Kim JH; Kim MJ; Suh SH; Chung JJ; Yoo HS; Lee JT
J Magn Reson Imaging; 2002 May; 15(5):573-83. PubMed ID: 11997899
[TBL] [Abstract][Full Text] [Related]
8. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
9. Hepatic hemangiomas: a multi-institutional study of appearance on T2-weighted and serial gadolinium-enhanced gradient-echo MR images.
Semelka RC; Brown ED; Ascher SM; Patt RH; Bagley AS; Li W; Edelman RR; Shoenut JP; Brown JJ
Radiology; 1994 Aug; 192(2):401-6. PubMed ID: 8029404
[TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinoma in cirrhosis: enhancement patterns at dynamic gadolinium- and superparamagnetic iron oxide-enhanced T1-weighted MR imaging.
Lutz AM; Willmann JK; Goepfert K; Marincek B; Weishaupt D
Radiology; 2005 Nov; 237(2):520-8. PubMed ID: 16192317
[TBL] [Abstract][Full Text] [Related]
11. [Role of magnetic resonance in the follow-up o hepatocarcinoma treated with percutaneous ethanol injection (PEI) or transarterial chemoembolization (TACE)].
De Cobelli F; Castrucci M; Sironi S; Livraghi T; Venturini M; Salvioni M; Del Maschio A
Radiol Med; 1994 Dec; 88(6):806-17. PubMed ID: 7878241
[TBL] [Abstract][Full Text] [Related]
12. Hepatocellular carcinoma in the cirrhotic liver: gadolinium-enhanced 3D T1-weighted MR imaging as a stand-alone sequence for diagnosis.
Hecht EM; Holland AE; Israel GM; Hahn WY; Kim DC; West AB; Babb JS; Taouli B; Lee VS; Krinsky GA
Radiology; 2006 May; 239(2):438-47. PubMed ID: 16641353
[TBL] [Abstract][Full Text] [Related]
13. Gadoxetic acid-enhanced hepatobiliary phase MRI and high-b-value diffusion-weighted imaging to distinguish well-differentiated hepatocellular carcinomas from benign nodules in patients with chronic liver disease.
Lee MH; Kim SH; Park MJ; Park CK; Rhim H
AJR Am J Roentgenol; 2011 Nov; 197(5):W868-75. PubMed ID: 22021534
[TBL] [Abstract][Full Text] [Related]
14. The value of gadobenate dimeglumine-enhanced delayed phase MR imaging for characterization of hepatocellular nodules in the cirrhotic liver.
Kim JI; Lee JM; Choi JY; Kim YK; Kim SH; Lee JY; Han JK; Choi BI
Invest Radiol; 2008 Mar; 43(3):202-10. PubMed ID: 18301317
[TBL] [Abstract][Full Text] [Related]
15. Renal lymphoma: demonstration by MR imaging.
Semelka RC; Kelekis NL; Burdeny DA; Mitchell DG; Brown JJ; Siegelman ES
AJR Am J Roentgenol; 1996 Apr; 166(4):823-7. PubMed ID: 8610558
[TBL] [Abstract][Full Text] [Related]
16. Importance of small (< or = 20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver: evaluation and comparison with whole explanted liver.
Holland AE; Hecht EM; Hahn WY; Kim DC; Babb JS; Lee VS; West AB; Krinsky GA
Radiology; 2005 Dec; 237(3):938-44. PubMed ID: 16306035
[TBL] [Abstract][Full Text] [Related]
17. Small (≤1-cm) hepatocellular carcinoma: diagnostic performance and imaging features at gadoxetic acid-enhanced MR imaging.
Yu MH; Kim JH; Yoon JH; Kim HC; Chung JW; Han JK; Choi BI
Radiology; 2014 Jun; 271(3):748-60. PubMed ID: 24588677
[TBL] [Abstract][Full Text] [Related]
18. Differentiating mass-forming intrahepatic cholangiocarcinoma from atypical hepatocellular carcinoma using gadoxetic acid-enhanced MRI.
Chong YS; Kim YK; Lee MW; Kim SH; Lee WJ; Rhim HC; Lee SJ
Clin Radiol; 2012 Aug; 67(8):766-73. PubMed ID: 22425613
[TBL] [Abstract][Full Text] [Related]
19. Can the patient with cirrhosis be imaged for hepatocellular carcinoma without gadolinium?: Comparison of combined T2-weighted, T2*-weighted, and diffusion-weighted MRI with gadolinium-enhanced MRI using liver explantation standard.
Hardie AD; Kizziah MK; Rissing MS
J Comput Assist Tomogr; 2011; 35(6):711-5. PubMed ID: 22082541
[TBL] [Abstract][Full Text] [Related]
20. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]